SCHEMBL2881336

SCHEMBL2881336

CC1CCC(C(=O)N(Cc2ccccn2)c2cc(-c3ccccc3)sc2OC(=O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.37
RAB9A P51151 2/20 0.36
KMT2A Q03164 1/20 0.36
CPB1 P15086 1/20 0.36
HTT P42858 2/20 0.35
CYP3A4 P08684 2/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
OPRM1 P35372 1/20 0.34
HTR1A P08908 1/20 0.34
DRD4 P21917 1/20 0.34
HTR2A P28223 1/20 0.34
HTR7 P34969 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2879544 0.88 SMN1; SMN2 (0.40) SMN1; SMN2LMNARAB9ACPB1HTT
SCHEMBL2881334 0.86 CPB1 (0.42) SMN1; SMN2LMNAKMT2ACPB1HTT
SCHEMBL2879462 0.84 CYP3A4 (0.52) LMNACPB1CYP3A4
SCHEMBL3811557 0.82 CPB1 (0.49) SMN1; SMN2LMNAKMT2ACPB1HTT
SCHEMBL2878325 0.80 HTT (0.36) LMNAKMT2ACPB1HTTCYP3A4
SCHEMBL3807275 0.79 CPB1 (0.40) SMN1; SMN2LMNARAB9AKMT2ACPB1
SCHEMBL3812146 0.79 KDM4E (0.41) RAB9AKMT2AHTTGAAKDM4E
SCHEMBL3807405 0.79 CPB1 (0.43) SMN1; SMN2KMT2ACPB1HTTCYP3A4
SCHEMBL3811469 0.79 CPB1 (0.43) KMT2ACPB1HTTKDM4EATM
SCHEMBL3811147 0.78 CPB1 (0.47) SMN1; SMN2LMNAKMT2ACPB1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed